Intercept Pharmaceuticals (NASDAQ:ICPT) Coverage Initiated at StockNews.com
StockNews.com assumed coverage on shares of Intercept Pharmaceuticals (NASDAQ:ICPT – Free Report) in a research note released on Saturday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Several other equities analysts have also issued reports on ICPT. Canaccord Genuity Group reiterated a hold rating and issued a $19.00 price objective (down from […]
More Stories
November US Trade Deficit Widens 94 Percent After Reaching 16-Year Low
By Andrew Moran The U.S. trade deficit in goods and services widened by the most since 1992, one month after...
AG Paxton Announces Investigation Into H-1B Visa Abuse
By Naveen Athrappully Texas Attorney General Ken Paxton is probing the abuse of the H-1B visa program in the state,...
Trump Shares Video Showing Earlier Violent Confrontation Between Pretti and Federal Agents
By Tom Ozimek President Donald Trump on Jan. 28 shared newly released video footage showing Alex Pretti in a violent...
Who is Angela Marmol? Height, Age, and News with Tom Cruise
A social media influencer, Angela, rose to fame through social media platforms like TikTok and Instagram. She is known for...
HHS Responds to Criticism From Vaccine Companies
By Zachary Stieber The Department of Health and Human Services (HHS) has responded after executives of top vaccine companies took...
Footsteps of Compassion: The Monks’ Epic Trek for a Fractured World
By Stephen Zogopoulos, USNN World News In a nation scarred by political rancor, economic inequality, and endless cycles of violence—both...